---
figid: PMC5143759__WJG-22-9921-g002
figlink: /pmc/articles/PMC5143759/figure/F2/
number: F2
caption: PIN1 dysregulation and targets in hepatocellular carcinoma. PIN1 functions
  as an amplifier to augment the oncogenic activities of key phosphoproteins involved
  in HCC tumourigenesis. PIN1 gene expression is up-regulated by various transcription
  factors, including E2F family and activated NOTCH1 intracellular domain (NCID),
  but is down-regulated by miRNAs (miR-200b/c and miR-296). In addition, PIN1 inactivates
  retinoblastoma protein (Rb), resulting in the release of E2F for activation of PIN1
  expression. Through phosphorylation-dependent prolyl isomerization, PIN1 activates
  the β-catenin/cyclin D1 signalling pathway by induction of β-catenin transcriptional
  activity and stabilization of cyclin D1 protein. In parallel, PIN1 increases the
  transcriptional activities of c-Jun and NF-κB, leading to an increase in cyclin
  D1 transcription. Furthermore, PIN1 stabilizes hepatitis B virus X protein (HBx)
  and enhances its transactivating activity on downstream target nuclear factor-kappa
  B (NF-κB), which in turn increases cyclin D1 transcription. Up-regulation of cyclin
  D1 leads to uncontrolled cell proliferation and tumourigenesis. In addition, PIN1
  increases the antiapoptotic function of survivin to inhibit apoptosis and contribute
  to tumourigenesis. Through interaction with Akt and ribosomal S6 kinase (p70S6K),
  PIN1 also activates the PI3K/Akt/mTOR pathway to promote tumourigenesis. PIN1 enhances
  the transcriptional activities of hypoxia-inducible factor (HIF)-1α and activator
  protein (AP)-1, resulting in up-regulation of angiogenic factor vascular endothelial
  growth factor (VEGF) and promotion of angiogenesis.
pmcid: PMC5143759
papertitle: Understanding the role of PIN1 in hepatocellular carcinoma.
reftext: Chi-Wai Cheng, et al. World J Gastroenterol. 2016 Dec 7;22(45):9921-9932.
pmc_ranked_result_index: '160066'
pathway_score: 0.9516233
filename: WJG-22-9921-g002.jpg
figtitle: PIN1 dysregulation and targets in hepatocellular carcinoma
year: '2016'
organisms: Homo sapiens
ndex: 56e4ddcf-def3-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5143759__WJG-22-9921-g002.html
  '@type': Dataset
  description: PIN1 dysregulation and targets in hepatocellular carcinoma. PIN1 functions
    as an amplifier to augment the oncogenic activities of key phosphoproteins involved
    in HCC tumourigenesis. PIN1 gene expression is up-regulated by various transcription
    factors, including E2F family and activated NOTCH1 intracellular domain (NCID),
    but is down-regulated by miRNAs (miR-200b/c and miR-296). In addition, PIN1 inactivates
    retinoblastoma protein (Rb), resulting in the release of E2F for activation of
    PIN1 expression. Through phosphorylation-dependent prolyl isomerization, PIN1
    activates the β-catenin/cyclin D1 signalling pathway by induction of β-catenin
    transcriptional activity and stabilization of cyclin D1 protein. In parallel,
    PIN1 increases the transcriptional activities of c-Jun and NF-κB, leading to an
    increase in cyclin D1 transcription. Furthermore, PIN1 stabilizes hepatitis B
    virus X protein (HBx) and enhances its transactivating activity on downstream
    target nuclear factor-kappa B (NF-κB), which in turn increases cyclin D1 transcription.
    Up-regulation of cyclin D1 leads to uncontrolled cell proliferation and tumourigenesis.
    In addition, PIN1 increases the antiapoptotic function of survivin to inhibit
    apoptosis and contribute to tumourigenesis. Through interaction with Akt and ribosomal
    S6 kinase (p70S6K), PIN1 also activates the PI3K/Akt/mTOR pathway to promote tumourigenesis.
    PIN1 enhances the transcriptional activities of hypoxia-inducible factor (HIF)-1α
    and activator protein (AP)-1, resulting in up-regulation of angiogenic factor
    vascular endothelial growth factor (VEGF) and promotion of angiogenesis.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - JUNB
  - CTNNB1
  - REL
  - RELA
  - FOSL1
  - NOTCH1
  - RPS6KB1
  - JUND
  - AKT3
  - NFKB2
  - FOSL2
  - RPS6KB2
  - MTOR
  - RELB
  - AKT1
  - JUN
  - CCND1
  - FOS
  - FOSB
  - VEGFB
  - VEGFA
  - NFKB1
  - PIN1
  - AKT2
  - VEGFC
  - BIRC5
  - HIF1A
  - PGF
  - VEGFD
  - Cancer
genes:
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUNB
  entrez: '3726'
- word: B-catenin
  symbol: beta-catenin
  source: hgnc_alias_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL1
  entrez: '8061'
- word: Notch1
  symbol: NOTCH1
  source: hgnc_symbol
  hgnc_symbol: NOTCH1
  entrez: '4851'
- word: P70S6K
  symbol: P70S6K
  source: bioentities_symbol
  hgnc_symbol: RPS6KB1
  entrez: '6198'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUND
  entrez: '3727'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL2
  entrez: '2355'
- word: P70S6K
  symbol: P70S6K
  source: bioentities_symbol
  hgnc_symbol: RPS6KB2
  entrez: '6199'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: CyclinD1
  symbol: Cyclin-D1
  source: bioentities_symbol
  hgnc_symbol: CCND1
  entrez: '595'
- word: C-Fos
  symbol: c-fos
  source: hgnc_alias_symbol
  hgnc_symbol: FOS
  entrez: '2353'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSB
  entrez: '2354'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: PIN1
  symbol: PIN1
  source: hgnc_symbol
  hgnc_symbol: PIN1
  entrez: '5300'
- word: c-Jun
  symbol: c-Jun
  source: hgnc_alias_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOS
  entrez: '2353'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: Survivin
  symbol: survivin
  source: hgnc_alias_symbol
  hgnc_symbol: BIRC5
  entrez: '332'
- word: HIF-1a
  symbol: HIF-1alpha
  source: hgnc_alias_symbol
  hgnc_symbol: HIF1A
  entrez: '3091'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC5143759__F2
redirect_from: /figures/PMC5143759__F2
figtype: Figure
---
